13 Recruiting Trials

Clinical Trials for Lupus in Missouri

13 clinical trials for Lupus are currently recruiting participants at study sites in Missouri. Study-related care is provided at no cost.

Showing 13 of 13 recruiting Lupus trials in Missouri

Recruiting
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
PHASE2 San Francisco, California +4 sites NCT05538208
Recruiting
VIBRANT: VIB4920 for Active Lupus Nephritis
PHASE2 La Jolla, California +4 sites NCT05201469
Recruiting
Recruiting
Lupus Landmark Study: A Prospective Registry and Biorepository
N/A Birmingham, Alabama +4 sites NCT05934149
Recruiting

Lupus clinical trials in Missouri: common questions

How many Lupus clinical trials are recruiting in Missouri?
TrialFinder currently lists 13 recruiting Lupus clinical trials with study sites in Missouri. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Lupus clinical trials located in Missouri?
Study sites for the Lupus trials listed on this page include St Louis. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a Lupus clinical trial in Missouri?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Lupus trials in Missouri also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Lupus clinical trial in Missouri?
Each study sets its own criteria based on age, Lupus diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.

Check Your Eligibility

Create a free profile and our AI will match you to Lupus trials near you in Missouri.

Get Matched — Free
No insurance required

Lupus trials evaluate belimumab, anifrolumab, JAK inhibitors, and other biologics targeting the immune dysregulation behind systemic lupus erythematosus.

All Lupus trials →